我要投票 香雪在中草药行业中的票数:512
· 外 推 电 报 ·
2025-08-06 21:44:56 星期三

【香雪是哪个国家的品牌?】

香雪是什么牌子?「香雪」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人王永辉在1986期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪品牌出海!将品牌入驻外推网,定制香雪品牌推广信息,可以显著提高香雪产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

广州市香雪制药股份有限公司总部位于广州经济技术开发区科学城,是一家以中成药制药和研发为主业,集西药制药、生物医学工程和药材规范种植于一体的现代化高新技术医药企业。

公司秉承“厚生臻善维新”的企业理念,坚持“崇尚品质;关爱健康”的质量方针,坚持自主创新、自主品牌,在品质、技术、研发、品牌和规模等多方面成长为行业领先者,得到消费者、行业和政府主管部门的高度评价和广泛认可,其中“香雪”商标获评中国驰名商标,“香雪抗病毒口服液”获评广东省名牌和广州市名牌产品,香雪制药获评“《福布斯》中国成长企业潜力榜100强”前五位,香雪制药获评“广东省医药产业50强企业”和“广州2010年亚运会药品供应商”等。

香雪制药一直致力于质量创新,致力于中药现代化的研究和实践,1998年开始进行中药现代化关键技术指纹图谱质量控制技术的研究,并取得重大突破。2001年,香雪抗病毒口服液指纹图谱质控研究被纳入广州名优中成药品种指纹图谱质量控制示范研究项目。2000年,香雪制药本着“实施中药系列标准规范,提高中成药品种质量”的理念,承担了国家科技部的“九五”重点科技攻关项目广藿香GAP种植基地,经过一年多的探索与研究,现已被国家科技部列入第一批国家中药现代化科技产业化(广东)基地,并通过国家验收。

香雪制药本着高起点、高技术、高标准、高速度的现代企业发展战略,采用先进的技术、工艺、设备,形成了完善、科学、先进的生产体系,使公司的产品质量和主要技术指标均达到了国内先进水平。公司坚持“创新”为企业的灵魂,以科技进步推动企业的发展。近年来承担了多项国家及省、市级重大科技专项技术的研究与开发;本着生产一代、储备一代、研制一代、构思一代的新产品开发战略。加快了疗效确切、科技含量高的新产品的研制开发。

英文翻译:Guangzhou Xiangxue Pharmaceutical Co., Ltd., headquartered in Science City, Guangzhou Economic and Technological Development Zone, is a modern high-tech pharmaceutical enterprise with Chinese patent medicine and R & D as its main business, integrating western medicine, biomedical engineering and standard planting of medicinal materials. The company adheres to the enterprise concept of "great life, perfect and innovative", and adheres to "advocating quality"; The company adheres to the quality policy of "care for health", adheres to independent innovation and independent brand, grows into the industry leader in quality, technology, R & D, brand and scale, and is highly appraised and widely recognized by consumers, industry and government authorities. Among them, "Xiangxue" trademark is awarded the famous trademark in China, and "Xiangxue antiviral oral liquid" is awarded the famous brand in Guangdong Province and Guangzhou city Brand products, Xiangxue pharmaceutical won the top five "Forbes China growth enterprise potential list top 100", Xiangxue pharmaceutical won the "top 50 pharmaceutical enterprises in Guangdong Province" and "drug supplier of Guangzhou 2010 Asian Games" and so on. Xiangxue pharmaceutical has been committed to quality innovation, research and practice of the modernization of traditional Chinese medicine. In 1998, it began to study the key technology of the modernization of traditional Chinese medicine fingerprint quality control technology, and made a major breakthrough. In 2001, the fingerprint quality control research of Xiangxue antiviral oral liquid was included in the quality control demonstration research project of Guangzhou famous and excellent Chinese patent medicine. In 2000, in line with the concept of "implementing the standards and specifications of traditional Chinese medicine series and improving the quality of traditional Chinese medicine varieties", Xiangxue pharmaceutical undertook the patchouli gap planting base, a key scientific and technological key project of the Ninth Five Year Plan of the Ministry of science and technology of the people's Republic of China. After more than a year's exploration and research, it has been listed in the first batch of national bases for the modernization of science and technology industrialization of traditional Chinese medicine (Guangdong) by the Ministry of science and technology of the people's Republic of China and passed the national acceptance 。 Based on the modern enterprise development strategy of high starting point, high technology, high standard and high speed, Xiangxue pharmaceutical adopts advanced technology, process and equipment to form a perfect, scientific and advanced production system, so that the product quality and main technical indicators of the company have reached the advanced level in China. The company adheres to "innovation" as the soul of the enterprise and promotes the development of the enterprise with the progress of science and technology. In recent years, it has undertaken the research and development of a number of national, provincial and municipal major science and technology special technologies; in line with the new product development strategy of production generation, storage generation, development generation and conception generation. The research and development of new products with precise curative effect and high technology content are accelerated.

本文链接: https://www.waitui.com/brand/f0447df2d.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

*ST亚振:股票交易异常波动,停牌核查

36氪获悉,*ST亚振公告,公司股票于2025年8月4日、5日、6日连续三个交易日内日收盘价格涨幅偏离值累计达到12%,属于股票交易异常波动。公司股票短期涨幅与同期上证指数、家具制造业存在严重偏离。公司将就股票交易情况进行核查,经申请,公司股票自2025年8月7日开市起停牌,自披露核查公告后复牌,预计停牌时间不超过10个交易日。公司提醒广大投资者注意二级市场交易风险。

2小时前

Shopify第二季度营收26.8亿美元,超出市场预期

Shopify美股盘前涨超10%。公司第二季度营收26.8亿美元,市场预估25.5亿美元;二季度订阅收入6.56亿美元,市场预估6.591亿美元;二季度营业利润2.91亿美元,市场预估2.477亿美元。(界面)

2小时前

理想汽车、中国汽研、东风柳汽发布联合声明

36氪获悉,理想汽车、中国汽研、东风柳汽发布联合声明:三方共同倡议:严守自律底线,共塑良性竞合:呼吁汽车行业严格自律,在产品研发、测试验证及宣传推广中,恪守诚信原则与商业道德,杜绝诸如贬损性对比等任何形式的不当竞争行为。检测认证机构应坚守专业准则,确保测试流程科学严谨,信息发布真实、准确、完整,共同维护风清气正的市场秩序。

2小时前

塔牌集团:拟5000万元—1亿元回购公司股份

36氪获悉,塔牌集团公告,拟5000万元—1亿元回购公司股份,用于公司实施员工持股计划,回购价格不超过10元/股(含)。

2小时前

三部门:到2027年全国完成新改建农村公路30万公里

36氪获悉,交通运输部、财政部、自然资源部印发《新一轮农村公路提升行动方案》,到2027年,全国完成新改建农村公路30万公里,便捷高效、普惠公平的农村公路网络基本建成;实施修复性养护工程30万公里,技术状况优良路率保持在70%以上,实施安全生命防护工程15万公里,改造危旧桥梁(含生命通道渡改桥、漫水桥)9000座,农村公路安全和服务保障能力进一步提升。

2小时前

本页详细列出关于香雪的品牌信息,含品牌所属公司介绍,香雪所处行业的品牌地位及优势。
咨询